… 27,564 patients with atherosclerotic cardiovascular disease and LDL cholesterol levels of
70 mg per deciliter (1.8 mmol per liter) or higher who were receiving statin therapy. Patients …

Background Influenza infection causes considerable morbidity and mortality in patients with
cardiovascular disease. We assessed the effects of the influenza vaccine on mortality and …

… Objective Previous studies that evaluated cardiovascular risk factors considered age as …
cardiovascular disease (CVD) and its risk factors on fatal outcomes according to age in patients …

The national burden of cardiovascular disease (CVD) continues to impose significant risk of
morbidity, mortality and increased costs. While traditional risk factors have been well-…

… with established cardiovascular disease, remains poorly … patients with cardiovascular disease
and severe obesity. … of MACE in patients with cardiovascular disease and obesity. These …

Objective Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic
syndrome and is associated with cardiovascular risk. The aim of this study was to determine …

… , especially among patients who have known cardiovascular disease, as … cardiovascular
disease, we required that study populations contained patients with: (a) coronary artery disease, …

… the effect of dapagliflozin in patients according to history of cardiovascular disease. For this
… with and without baseline cardiovascular disease. Cardiovascular disease was defined as …

Background In the general population, raised levels of inflammatory markers are stronger
predictors of fatal than nonfatal cardiovascular disease ( CVD ) events. People with HIV have …

… Information regarding the impact of cardiovascular complication on fatal outcome is scarce.
… cardiovascular disease (CVD) and myocardial injury with fatal outcomes in patients with …